After a massive 17.7% decline in February, the Canadian Cannabis LP Index recovered just some of the losses in March, rallying 0.8% after having been up more than 13% earlier in...
Canabo Medical Inc. Announces Proposed Business Combination with Aleafia Inc. Halifax, Nova Scotia–(Newsfile Corp. – December 22, 2017) – Canabo Medical Inc. (TSXV: CMM) (“Canabo” or the “Company”) is...
Canadian LP Aphria (TSX: APH) (OTC: APHQF), which purchased a 6mm share stake in Canabo Medical Corp (TSXV: CMM) (OTC: CAMDF) at $1.40 per share in December, has sharply reduced...
Milestone Study Shows Dramatic Reduction In Pharmaceutical Reliance Among Canadian Medical Cannabis Patients Canabo Medical Inc. observational study finds nearly fifty per cent drop in benzodiazepine use within months...
Editor’s note: On March 16th, Aphria filed on SEDI that it had bought back the 500K shares at $0.74 on March 13th Just thirteen weeks after agreeing to pay $1.40 for...
Most investors are familiar with Aphria (TSXV: APH) (OTC: APHQF) as a leading licensed producer in Canada, but many may not realize that it is rapidly building a substantial portfolio of...
Canabo Medical (TSXV: CMM) (OTC: CAMDF) announced that it has closed its $8.4 financing with Aphria (TSXV: APH) (OTC: APHQF), selling the licensed producer 6mm shares at $1.40 in...
